Physician profile
Lorne S Label
NPI 1841262193
$1,897.09
in general payments reported to CMS, 2019-2025
23 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $66.21 · 2021: $634 · 2022: $496 · 2023: $264 · 2024: $113 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $425.51 | 2019-2022 | |
| Abbvie INC. | $310.65 | 2021-2023 | |
| Ucb, INC. | $220.97 | 2021-2025 | Briviact |
| Allergan, INC. | $156.45 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $95.82 | 2021-2022 | |
| Stryker Corporation | $90.64 | 2023 | Trevo |
| Biohaven Pharmaceuticals, INC. | $86.71 | 2021 | |
| Saluda Medical Americas, INC. | $62.53 | 2023 | Evoke Scs |
| Acadia Pharmaceuticals INC | $52.09 | 2021-2025 | Daybue |
| Viz.Ai, INC. | $50.00 | 2021-2022 | |
| Sk Life Science, INC. | $44.24 | 2021-2025 | |
| Pfizer INC. | $43.19 | 2023 | |
| Upsher-Smith Laboratories LLC | $40.91 | 2021-2022 | |
| Ceribell, INC. | $26.54 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.51 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $25.01 | 2022 | |
| Amneal Pharmaceuticals LLC | $24.31 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $22.51 | 2022 | |
| Neurocrine Biosciences, INC. | $21.28 | 2022 | |
| Horizon Therapeutics Plc | $19.60 | 2021 | |
| Biogen, INC. | $17.88 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.55 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorne Label listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.